Are Insulin Analogues Detemir or Glulisine Used Preferentially in Overweight/Obese Subjects? A German Multicentre Analysis of 38560 Type 2 Diabetic Patients from the DPV Registry
Erstveröffentlichung
2014
Wissenschaftlicher Artikel
Published in
Experimental and Clinical Endocrinology & Diabetes ; 122 (2014), 10. - S. 602-607. - ISSN 0947-7349. - eISSN 1439-3646
Link to publication
https://dx.doi.org/10.1055/s-0034-1383646Faculties
Medizinische FakultätInstitutions
Institut für Epidemiologie und Medizinische BiometrieUKU. Klinik für Innere Medizin I
Subject headings
[Free subject headings]: insulin analogues | detemir | glulisine | type 2 diabetes | body mass index | LESS WEIGHT-GAIN | NPH INSULIN | FASTER ONSET | PHARMACOKINETICS | PHARMACODYNAMICS | METAANALYSIS | GLARGINE | THERAPY | ASPART | RISK[DDC subject group]: DDC 610 / Medicine & health